An atlas of genetic influences on human blood metabolites SY Shin, EB Fauman, AK Petersen, J Krumsiek, R Santos, J Huang, ... Nat Genet 46 (6), 543-550, 2014 | 1275 | 2014 |
Connecting genetic risk to disease end points through the human blood plasma proteome K Suhre, M Arnold, AM Bhagwat, RJ Cotton, R Engelke, J Raffler, ... Nature communications 8 (1), 1-14, 2017 | 581 | 2017 |
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—an emerging role for gut microbiome S MahmoudianDehkordi, M Arnold, K Nho, S Ahmad, W Jia, G Xie, ... Alzheimer's & Dementia 15 (1), 76-92, 2019 | 474 | 2019 |
Metabolic network failures in Alzheimer's disease: A biochemical road map JB Toledo, M Arnold, G Kastenmüller, R Chang, RA Baillie, X Han, ... Alzheimer's & Dementia 13 (9), 965-984, 2017 | 399 | 2017 |
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. VR Varma, AM Oommen, S Varma, R Casanova, Y An, RM Andrews, ... PLoS medicine 15 (1), e1002482, 2018 | 384 | 2018 |
SNiPA: an interactive, genetic variant-centered annotation browser M Arnold, J Raffler, A Pfeufer, K Suhre, G Kastenmüller Bioinformatics 31 (8), 1334-1336, 2015 | 306 | 2015 |
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers K Nho, A Kueider-Paisley, S MahmoudianDehkordi, M Arnold, ... Alzheimer's & Dementia 15 (2), 232-244, 2019 | 241 | 2019 |
Mapping the proteo-genomic convergence of human diseases M Pietzner, E Wheeler, J Carrasco-Zanini, A Cortes, M Koprulu, ... Science, 2021 | 222 | 2021 |
Alzheimer’s risk factors age, APOE genotype, and sex drive distinct molecular pathways N Zhao, Y Ren, Y Yamazaki, W Qiao, F Li, LM Felton, ... Neuron 106 (5), 727-742. e6, 2020 | 175 | 2020 |
Plasma proteomic associations with genetics and health in the UK Biobank BB Sun, J Chiou, M Traylor, C Benner, YH Hsu, TG Richardson, ... Nature, 1-10, 2023 | 169* | 2023 |
Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers K Nho, A Kueider-Paisley, S Ahmad, S MahmoudianDehkordi, M Arnold, ... JAMA network open 2 (7), e197978-e197978, 2019 | 169 | 2019 |
Multi-omics integration in biomedical research–A metabolomics-centric review MA Wörheide, J Krumsiek, G Kastenmüller, M Arnold Analytica Chimica Acta 1141, 144-162, 2021 | 155 | 2021 |
Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome M Arnold, K Nho, A Kueider-Paisley, T Massaro, K Huynh, B Brauner, ... Nature communications 11 (1), 1148, 2020 | 134 | 2020 |
Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer’s disease P Baloni, CC Funk, J Yan, JT Yurkovich, A Kueider-Paisley, K Nho, ... Cell Reports Medicine 1 (8), 2020 | 126 | 2020 |
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease K Huynh, WLF Lim, C Giles, KS Jayawardana, A Salim, NA Mellett, ... Nature Communications 11 (1), 5698, 2020 | 93 | 2020 |
Genome-wide association study with targeted and non-targeted NMR metabolomics identifies 15 novel loci of urinary human metabolic individuality J Raffler, N Friedrich, M Arnold, T Kacprowski, R Rueedi, E Altmaier, ... PLoS genetics 11 (9), e1005487, 2015 | 92 | 2015 |
Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions SK Sieberts, TM Perumal, MM Carrasquillo, M Allen, JS Reddy, ... Scientific data 7 (1), 340, 2020 | 84 | 2020 |
Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease E Horgusluoglu, R Neff, WM Song, M Wang, Q Wang, M Arnold, ... Alzheimer's & Dementia 18 (6), 1260-1278, 2022 | 73 | 2022 |
Serum triglycerides in Alzheimer's disease: Relation to neuroimaging and CSF biomarkers M Bernath, S Bhattacharyya, K Nho, D Barupal, O Fiehn, R Baillie, ... Neurology 94 (20), e2088-e2098, 2020 | 70 | 2020 |
Targeted metabolomics and medication classification data from participants in the ADNI1 cohort L St John-Williams, C Blach, JB Toledo, DM Rotroff, S Kim, K Klavins, ... Scientific data 4 (1), 1-11, 2017 | 65 | 2017 |